Will I feel worse before I feel better
reports personal fees from AstraZeneca, Bayer Vital GmbH, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, MSD, Novartis, Pharmacosmos, Sanofi, Servier, Synlab, Amgen and Amarin outside the submitted work
If you have moved up too quickly and side effects are significant, your clinician may recommend stepping back to the previous dose temporarily and titrating more slowly
External resources American College of Rheumatology: GLP-1 therapies in rheumatic disease Frontiers in Immunology: GLP-1 as modulator of innate immunity Cell and Bioscience: GLP-1 receptor agonists in autoimmune diseases For researchers serious about understanding how GLP-1 receptor agonists intersect with autoimmune management, SeekPeptides provides the most comprehensive resource available, with evidence-based protocols, detailed mechanism guides, and a community of thousands navigating these exact questions about peptide-based approaches to inflammation and immune health